Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Rationale for, initiation and titration of the basal insulin/GLP-1RA fixed-ratio combination products, IDegLira and IGlarLixi, for the management of type 2 diabetes
Ortuno et al
Start Your Free Assessment
Farr S, Taher J, Adeli K
Analyses were conducted using non-compartmental methods in the statistical software SAS, version 9.4 M5
In the adjusted cause-specific-hazard regression for the GLP-1 RA vs DPP-4 inhibitor cohort, GLP-1 RAs were associated with a lower risk of suicide or suicide attempts compared with DPP-4 inhibitors after 1 year follow-up (HR 365 0.58 [0.37;0.91])
US$ 24.43
US$ 20.78
US$ 26.69
US$ 21.60
US$ 22.46
US$ 25.90
